SpringerProtocols: Abstract: 4. Genetic Epidemiology Studies in Hereditary Non-Polyposis Colorectal Cancer

4. Genetic Epidemiology Studies in Hereditary Non-Polyposis Colorectal Cancer

By: Rodney J. Scott³, Jan Lubinski⁴

Abstract

Full Text

Download PDF (178K)

Genetic epidemiology studies in hereditary non-polyposis colorectal cancer (HNPCC) have the potential to radically improve assessment of disease risk such that more individualised information can be provided to patients susceptible to developing disease. Studies of HNPCC initially focused on disease associations and the definition of the disease and its association with different cancers within the context of an inherited predisposition. With the identification of the genetic basis of HNPCC, new insights into the disease have been forthcoming and many advances in our understanding have been made. There have been many reports examining potential modifier genes in HNPCC, yet the results remain controversial as many findings have not been replicated and therefore no clear consensus as to the role of specific modifier genes has been reached. This review focuses on some of the factors associated with disease risk in HNPCC and where some of the difficulties lie in assessing the value of genetic epidemiology studies in this disorder.

Affiliation(s): (3) Discipline of Medical Genetics, School of Biomedical Sciences, University of Newcastle and the Hunter Medical Research Institute, Newcastle New South Wales, Australia
(4) International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

Book Title: Cancer Epidemiology: Modifiable Factors

Series: Methods in Molecular Biology | Volume: 472 | Pub. Date: Sep-12-2008 | Page Range: 89-102 | DOI: 10.1007/978-1-60327-492-0_4

Subject: Cancer Research

Key Words: HNPCC - Lynch syndrome - genetic epidemiology - modifier genes

References

Download References

1.	Watson, P. and H.T. Lynch, Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer, 1993. 71 (3): p. 677–685.

2.	Lynch, H.T., S. Lanspa, T. Smyrk, B. Boman, P. Watson, and J. Lynch, Hereditary non-polyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet Cytogenet, 1991. 53 (2): p. 143–160.

3.	Fishel, R., M.K. Lescoe, M.R. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, and R. Kolodner, The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 1993. 75 (5): p. 1027–1038.

4.	Nicolaides, N.C., N. Papadopoulos, B. Liu, Y.F. Wei, K.C. Carter, S.M. Ruben, C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C.M. Fraser, et al., Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 1994. 371 (6492): p. 75–80.

5.	Bronner, C.E., S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith, M.K. Lescoe, M. Kane, C. Earabino, J. Lipford, A. Lind-blom, et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 1994. 368 (6468): p. 258–261.

6.	Miyaki, M., M. Konishi, K. Tanaka, R. Kikuchi-Yanoshita, M. Muraoka, M. Yasuno, T. Igari, M. Koike, M. Chiba, and T. Mori, Germline mutation of MSH6 as the cause of hereditary nonpolyposis color-ectal cancer. Nat Genet, 1997. 17 (3): p. 271–272.

7.	Liu, T., H. Yan, S. Kuismanen, A. Per-cesepe, M.L. Bisgaard, M. Pedroni, P. Ben-atti, K.W. Kinzler, B. Vogelstein, M. Ponz de Leon, P. Peltomaki, and A. Lindblom, The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res, 2001. 61 (21): p. 7798–7802.

8.	Peltomaki, P., Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol, 2003. 21 (6): p. 1174–1179.

9.	Scott, R.J., M. McPhillips, C.J. Meldrum, P.E. Fitzgerald, K. Adams, A.D. Spigelman, D. du Sart, K. Tucker, and J. Kirk, Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet, 2001. 68 (1): p. 118–127.

10.	Wijnen, J.T., H.F. Vasen, P.M. Khan, A.H. Zwinderman, H. van der Klift, A. Mulder, C. Tops, P. Moller, and R. Fodde, Clinical findings with implications for genetic testing in families with clustering of colorec-tal cancer. N Engl J Med, 1998. 339 (8): p. 511–518.

11.	De Rosa, M., C. Fasano, L. Panariello, M.I. Scarano, G. Belli, A. Iannelli, F. Ciciliano, and P. Izzo, Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene, 2000. 19 (13): p. 1719–1723.

12.	Hamilton, S.R., B. Liu, R.E. Parsons, N. Papadopoulos, J. Jen, S.M. Powell, A.J. Krush, T. Berk, Z. Cohen, B. Tetu, et al., The molecular basis of Turcot's syndrome. N Engl J Med, 1995. 332 (13): p. 839–847.

13.	Felton, K.E., D.M. Gilchrist, and S.E. Andrew, Constitutive deficiency in DNA mismatch repair. Clin Genet, 2007. 71 (6): p. 483–498.

14.	Felton, K.E., D.M. Gilchrist, and S.E. Andrew, Constitutive deficiency in DNA mismatch repair: is it time for Lynch III ? Clin Genet, 2007. 71 (6): p. 499–500.

15.	Peltomaki, P., Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet, 2001. 10 (7): p. 735–740.

16.	Vasen, H.F., Y. Hendriks, A.E. de Jong, M. van Puijenbroek, C. Tops, A.H. Brocker-Vriends, J.T. Wijnen, and H. Morreau, Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers, 2004. 20 (4–5): p. 207–213.

17.	Vasen, H.F., J.P. Mecklin, P.M. Khan, and H.T. Lynch, The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum, 1991. 34 (5): p. 424–425.

18.	Fornasarig, M., A. Viel, E. Bidoli, E. Cam-pagnutta, A.M. Minisini, R. Cannizzaro, L. Della Puppa, and M. Boiocchi, Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC families. Tumori, 2002. 88 (1): p. 18–20.

19.	Rodriguez-Bigas, M.A., C.R. Boland, S.R. Hamilton, D.E. Henson, J.R. Jass, P.M. Khan, H. Lynch, M. Perucho, T. Smyrk, L. Sobin, and S. Srivastava, A National Cancer Institute Workshop on Hereditary Nonpoly-posis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst, 1997. 89 (23): p. 1758–1762.

20.	Umar, A., C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, and S. Srivastava, Revised Bethesda Guidelines for hereditary nonpoly-posis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst, 2004. 96 (4): p. 261–268.

21.	Kladny, J., G. Moeslein, T. Myrhoj, G. Kurzawski, A. Jakubowska, T. Debniak, W. Petriczko, M. Kozlowski, T. Al-Amawi, M. Brzosko, J. Flicinski, A. Jawien, Z. Banaszkiewicz, P. Rychter, and J. Lubin-ski, Nuclear Pedigree Criteria of Suspected HNPCC. Hereditary Cancer in Clinical Practice, 2003. 1.0 (1): p. 34–38.

22.	Katballe, N., M. Christensen, F.P. Wikman, T.F. Orntoft, and S. Laurberg, Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut, 2002. 50 (1): p. 43–51.

23.	Lamberti, C., E. Mangold, C. Pagenstecher, M. Jungck, D. Schwering, M. Bollmann, J. Vogel, D. Kindermann, R. Nikorowitsch, N. Friedrichs, B. Schneider, F. Housh-daran, I.G. Schmidt-Wolf, W. Friedl, P. Propping, T. Sauerbruch, R. Buttner, and M. Mathiak, Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion, 2006. 74 (1): p. 58–67.

24.	Lynch, H.T. and A. de la Chapelle, Hereditary colorectal cancer. N Engl J Med, 2003. 348 (10): p. 919–932.

25.	Dunlop, M.G., S.M. Farrington, A.D. Carothers, A.H. Wyllie, L. Sharp, J. Burn, B. Liu, K.W. Kinzler, and B. Vogelstein, Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet, 1997. 6 (1): p. 105–110.

26.	Aarnio, M., J.P. Mecklin, L.A. Aaltonen, M. Nystrom-Lahti, and H.J. Jarvinen, Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer, 1995. 64 (6): p. 430–433.

27.	Vasen, H.F., J.T. Wijnen, F.H. Menko, J.H. Kleibeuker, B.G. Taal, G. Griffioen, F.M. Nagengast, E.H. Meijers-Heijboer, L. Bertario, L. Varesco, M.L. Bisgaard, J. Mohr, R. Fodde, and P.M. Khan, Cancer risk in families with hereditary nonpolypo-sis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 1996. 110 (4): p. 1020–1027.

28.	Voskuil, D.W., H.F. Vasen, E. Kampman, and P. van't Veer, Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC. Int J Cancer, 1997. 72 (2): p. 205–209.

29.	Hampel, H., J.A. Stephens, E. Pukkala, R. Sankila, L.A. Aaltonen, J.P. Mecklin, and A. de la Chapelle, Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology, 2005. 129 (2): p. 415–421.

30.	Aarnio, M., R. Sankila, E. Pukkala, R. Salovaara, L.A. Aaltonen, A. de la Chapelle, P. Peltomaki, J.P. Mecklin, and H.J. Jarvinen, Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer, 1999. 81 (2): p. 214–218.

31.	Carayol, J., M. Khlat, J. Maccario, and C. Bonaiti-Pellie, Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet, 2002. 39 (5): p. 335–339.

32.	Parc, Y., C. Boisson, G. Thomas, and S. Ols-chwang, Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet, 2003. 40 (3): p. 208–213.

33.	Quehenberger, F., H.F. Vasen, and H.C. van Houwelingen, Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet, 2005. 42 (6): p. 491–496.

34.	Alarcon, F., C. Lasset, J. Carayol, V. Bona-dona, H. Perdry, F. Desseigne, Q. Wang, and C. Bonaiti-Pellie, Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet, 2007. 15 (8): p. 831–836.

35.	Vasen, H.F., H. Morreau, and J.W. Nortier, Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer ? Am J Hum Genet, 2001. 68 (6): p. 1533–1535.

36.	Oliveira Ferreira, F., C.C. Napoli Ferreira, B.M. Rossi, W. Toshihiko Nakagawa, S. Aguilar, Jr., E.M. Monteiro Santos, M.L. Vierira Costa, and A. Lopes, Frequency of extra-colonic tumors in hereditary non-polyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer, 2004. 3 (1): p. 41–47.

37.	Risinger, J.I., J.C. Barrett, P. Watson, H.T. Lynch, and J. Boyd, Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer, 1996. 77 (9): p. 1836–1843.

38.	Boyd, J., E. Rhei, M.G. Federici, P.I. Borgen, P. Watson, B. Franklin, B. Karr, J. Lynch, S.J. Lemon, and H.T. Lynch, Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat, 1999. 53 (1): p. 87–91.

39.	de Leeuw, W.J., M. van Puijenbroek, R.A. Tollenaar, C.J. Cornelisse, H.F. Vasen, and H. Morreau, Correspondence re: A. Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014–1019, 2002. Cancer Res, 2003. 63 (5): p. 1148–1149.

40.	Watson, P. and B. Riley, The tumor spectrum in the Lynch syndrome. Fam Cancer, 2005. 4 (3): p. 245–248.

41.	den Bakker, M.A., C. Seynaeve, M. Kliffen, and W.N. Dinjens, Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis color-ectal cancer. Histopathology, 2003. 43 (3): p. 297–299.

42.	Vasen, H.F., A. Stormorken, F.H. Menko, F.M. Nagengast, J.H. Kleibeuker, G. Grif-fioen, B.G. Taal, P. Moller, and J.T. Wijnen, MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorec-tal cancer families. J Clin Oncol, 2001. 19 (20): p. 4074–4080.

43.	Bandipalliam, P., J. Garber, R.D. Kolodner, and S. Syngal, Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology, 2004. 126 (3): p. 936–937.

44.	Bandipalliam, P., Variability in the clinical phenotype among families with HNPCC— the potential importance of the location of the mutation in the gene. Int J Cancer, 2007. 120 (10): p. 2275–2277; author reply 2278.

45.	Hayward, B.E., M. De Vos, E. Sheridan, and D.T. Bonthron, PMS2 mutations in HNPCC. Clin Genet, 2004. 66 (6): p. 566–567; author reply 568.

46.	De Vos, M., B.E. Hayward, S. Picton, E. Sheridan, and D.T. Bonthron, Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet, 2004. 74 (5): p. 954–964.

47.	Hendriks, Y.M., A. Wagner, H. Morreau, F. Menko, A. Stormorken, F. Quehenberger, L. Sandkuijl, P. Moller, M. Genuardi, H. Van Houwelingen, C. Tops, M. Van Pui-jenbroek, P. Verkuijlen, G. Kenter, A. Van Mil, H. Meijers-Heijboer, G.B. Tan, M.H. Breuning, R. Fodde, J.T. Wijnen, A.H. Brocker-Vriends, and H. Vasen, Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology, 2004. 127 (1): p. 17–25.

48.	Kolodner, R.D., J.D. Tytell, J.L. Schmeits, M.F. Kane, R.D. Gupta, J. Weger, S. Wahlberg, E.A. Fox, D. Peel, A. Ziogas, J.E. Garber, S. Syngal, H. Anton-Culver, and F.P. Li, Germ-line msh6 mutations in colorectal cancer families. Cancer Res, 1999. 59 (20): p. 5068–5074.

49.	Plaschke, J., C. Engel, S. Kruger, E. Holin-ski-Feder, C. Pagenstecher, E. Mangold, G. Moeslein, K. Schulmann, J. Gebert, M. von Knebel Doeberitz, J. Ruschoff, M. Loeffler, and H.K. Schackert, Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Color-ectal Cancer Consortium. J Clin Oncol, 2004. 22 (22): p. 4486–4494.

50.	Wijnen, J., W. de Leeuw, H. Vasen, H. van der Klift, P. Moller, A. Stormorken, H. Meijers-Heijboer, D. Lindhout, F. Menko, S. Vossen, G. Moslein, C. Tops, A. Brocker-Vriends, Y. Wu, R. Hofstra, R. Sijmons, C. Cornelisse, H. Morreau, and R. Fodde, Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet, 1999. 23 (2): p. 142–144.

51.	Mary, J.L., T. Bishop, R. Kolodner, J.R. Lip-ford, M. Kane, W. Weber, J. Torhorst, H. Muller, M. Spycher, and R.J. Scott, Muta-tional analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development. Hum Mol Genet, 1994. 3 (11): p. 2067–2069.

52.	Moisio, A.L., P. Sistonen, J.P. Mecklin, H. Jarvinen, and P. Peltomaki, Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpoly-posis colon cancer. Gastroenterology, 1998. 115 (6): p. 1387–1394.

53.	Brown, S.R., P.J. Finan, and D.T. Bishop, Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer ? Gut, 1998. 43 (5): p. 664–668.

54.	Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand J Gastroenterol, 2007. 42 (5): p. 628–632.

55.	Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis color-ectal cancer patients. Cancer Epidemiol Biomarkers Prev, 2006. 15 (11): p. 2307–2310.

56.	Shin, J.H., J.L. Ku, K.H. Shin, Y.K. Shin, S.B. Kang, and J.G. Park, Glutathione S-transferase M1 associated with cancer occurrence in Korean HNPCC families carrying the hMLH1/hMSH2 mutation. Oncol Rep, 2003. 10 (2): p. 483–486.

57.	Bala, S. and P. Peltomaki, CYCLIN D1 as a genetic modifier in hereditary nonpoly-posis colorectal cancer. Cancer Res, 2001. 61 (16): p. 6042–6045.

58.	Chen, J., S. Sen, C.I. Amos, C. Wei, J.S. Jones, P. Lynch, and M.L. Frazier, Associa tion between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol Carcinog, 2007. 46 (4): p. 249–256.

59.	Heinimann, K., R.J. Scott, P. Chappuis, W. Weber, H. Muller, Z. Dobbie, and P. Hutter, N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res, 1999. 59 (13): p. 3038–3040.

60.	Pistorius, S., H. Goergens, C. Engel, J. Plaschke, S. Krueger, R. Hoehl, H.D. Saeger, and H.K. Schackert, N-Acetyltrans-ferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) color-ectal cancer. Int J Colorectal Dis, 2007. 22 (2): p. 137–143.

61.	Frazier, M.L., F.T. O'Donnell, S. Kong, X. Gu, I. Campos, R. Luthra, P.M. Lynch, and C.I. Amos, Age-associated risk of cancer among individuals with N-acetyltrans-ferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res, 2001. 61 (4): p. 1269–1271.

62.	Ketterer, B., Protective role of glutathione and glutathione transferases in mutagen-esis and carcinogenesis. Mutat Res, 1988. 202 (2): p. 343–361.

63.	Helzlsouer, K.J., O. Selmin, H.Y. Huang, P.T. Strickland, S. Hoffman, A.J. Alberg, M. Watson, G.W. Comstock, and D. Bell, Association between glutathione S-trans-ferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst, 1998. 90 (7): p. 512–518.

64.	Felix, R., W. Bodmer, N.S. Fearnhead, L. van der Merwe, P. Goldberg, and R.S. Ramesar, GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat Res, 2006. 602 (1–2): p. 175–181.

65.	Campbell, P.T., L. Edwards, J.R. McLaughlin, J. Green, H.B. Younghusband, and M.O. Woods, Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland. Clin Cancer Res, 2007. 13 (13): p. 3783–3788.

66.	Esteller, M., A. Garcia, J.M. Martinez-Pal-ones, J. Xercavins, and J. Reventos, Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahy-drofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcino-genesis, 1997. 18 (12): p. 2307–2311.

67.	Zhang, Z.W., P. Newcomb, A. Hollowood, R. Feakins, M. Moorghen, A. Storey, M.J. Farthing, D. Alderson, and J. Holly, Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res, 2003. 9 (6): p. 2151–2156.

68.	Bougeard, G., S. Baert-Desurmont, I. Tournier, S. Vasseur, C. Martin, L. Brugieres, A. Chompret, B. Bressac-de Paillerets, D. Stoppa-Lyonnet, C. Bonaiti-Pellie, and T. Frebourg, Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J Med Genet, 2006. 43 (6): p. 531–533.

69.	Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer, 2006. 118 (10): p. 2479–2484.

70.	Talseth, B.A., C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott, MDM2 SNP309 T <G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer, 2007. 120 (3): p. 563–565.

71.	Sotamaa, K., S. Liyanarachchi, J.P. Meck-lin, H. Jarvinen, L.A. Aaltonen, P. Pelto-maki, and A. de la Chapelle, p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res, 2005. 11 (19 Pt 1): p. 6840–6844.

72.	Kong, S., C.I. Amos, R. Luthra, P.M. Lynch, B. Levin, and M.L. Frazier, Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res, 2000. 60 (2): p. 249–252.

73.	Kruger, S., C. Engel, A. Bier, E. Mangold, C. Pagenstecher, M.K. Doeberitz, E. Holinski-Feder, G. Moeslein, G. Keller, E. Kunstmann, W. Friedl, J. Plaschke, J. Ruschoff, and H.K. Schackert, Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett, 2006. 236 (2): p. 191–197.

74.	Talseth, B.A., K.A. Ashton, C. Meldrum, J. Suchy, G. Kurzawski, J. Lubinski, and R.J. Scott. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer, 2008. 122 : p1273–1277.

75.	Maillet, P., P.O. Chappuis, G. Vaudan, Z. Dobbie, H. Muller, P. Hutter, and A.P. Sappino, A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer, 2000. 88 (6): p. 928–931.

76.	Jones, J.S., X. Gu, P.M. Lynch, M. Rod-riguez-Bigas, C.I. Amos, and M.L. Frazier, ATM polymorphism and hereditary nonpoly-posis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control, 2005. 16 (6): p. 749–753.

Comments (Loading...)

Post comment/View all comments